Fractyl Health Receives Nasdaq Delisting Notice for Sub-$1.00 Bid Price
Summary
Fractyl Health, Inc. received a Nasdaq notice for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day period to regain compliance and avoid potential delisting.
Key Events
-
Nasdaq Minimum Bid Price Deficiency
On March 13, 2026, Fractyl Health, Inc. received a notice from Nasdaq for non-compliance with Listing Rule 5450(a)(1), as its common stock traded below $1.00 for 30 consecutive business days.
-
180-Day Compliance Period Initiated
The company has 180 calendar days, until September 9, 2026, to regain compliance by having its stock close at $1.00 or more for at least 10 consecutive business days.
-
Potential Delisting or Reverse Stock Split
Failure to regain compliance could lead to delisting or require a transfer application to the Nasdaq Capital Market, potentially necessitating a reverse stock split to meet bid price requirements.
Analysis
Fractyl Health, Inc. has received a formal notice from Nasdaq regarding its non-compliance with the minimum $1.00 bid price rule. This is a critical development as it signals significant market underperformance and poses a direct threat to the company's listing on the Nasdaq Global Market. While the company has 180 days to regain compliance, the current stock price of $0.46 indicates a substantial gap to close. Failure to comply could lead to a transfer to the Nasdaq Capital Market (which still requires meeting other listing standards) or, ultimately, delisting. A reverse stock split, often considered a last resort, is explicitly mentioned as a potential option, which can be viewed negatively by investors.
At the time of this filing, GUTS was trading at $0.46 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $62.9M. The 52-week trading range was $0.38 to $3.03. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.